Benchmarking a Respiratory PCR Panel for FDA Submission

This case study highlights the benchmarking of a respiratory PCR panel to support FDA submission by comparing its performance against an FDA-cleared reference assay. The study focused on key validation metrics, including limit of detection (LOD), sensitivity, specificity, and false positive/negative rates under real clinical conditions. Results demonstrated strong agreement with the reference method, confirming the assay’s accuracy and reliability for detecting respiratory pathogens. The work underscores the importance of rigorous clinical validation and method comparison studies in achieving regulatory approval for molecular diagnostics.